CRISPR Therapeutics announces FDA Regenerative Medicine Advanced Therapy (RMAT) designation granted to CTX110™

Clinical Impact

Nov 22

Written By Frances Benson

https://crisprtx.gcs-web.com/news-releases/news-release-details/crispr-therapeutics-announces-fda-regenerative-medicine-advanced

2021

Frances Benson

HotSpot Therapeutics raises $100M in Series C

Palleon presents data on sialoglycan degradation platform that enhances anti-tumor T-cell immunity